# Michael Smylie

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-smylie/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,048 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 43 |
| i10-index | 80 |
| OpenAlex ID | https://openalex.org/A5015975033 |
| ORCID iD | https://orcid.org/0000-0001-5945-0397 |
| Works | 137 |

## Researcher papers

- [Erlotinib in Previously Treated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/erlotinib-in-previously-treated-non-small-cell-lung-cancer/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.